Form 4: DENTSPLY SIRONA Director Boosts Equity Holdings

Jonathan Jay Mazelsky, a director at DENTSPLY SIRONA Inc., acquired 2,637.9487 shares of phantom stock as part of a deferred compensation plan.

Summary

• Jonathan Jay Mazelsky, a Director of DENTSPLY SIRONA Inc. (XRAY), reported an acquisition of phantom stock.
• On December 31, 2026, Mr. Mazelsky acquired 2,637.9487 shares of phantom stock through a Directors' Deferred Compensation plan.
• Each share of phantom stock is the economic equivalent of one share of common stock.
• The phantom stock becomes payable in common stock upon Mr. Mazelsky's termination of service as a director.
• The acquisition was made at a price of $11.37 per phantom stock unit.
• Following this transaction, Mr. Mazelsky beneficially owns a total of 14,381.5129 shares of phantom stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), with an earliest transaction date of December 31, 2025.

Sentiment

Score: 7

Explanation: The acquisition of phantom stock by a director, even as deferred compensation, indicates continued alignment with shareholder interests and a long-term commitment to the company.

Positives

• A director increasing their beneficial ownership, even through deferred compensation, signals continued alignment with the company's long-term interests and performance.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned, non-discretionary acquisition.

Future Outlook

The phantom stock acquired becomes payable in common stock upon the reporting person's termination of service as a director, indicating a long-term incentive structure.

Industry Context

This is an individual insider transaction, reflecting a director's compensation and equity stake in the company. It does not directly relate to broader industry trends but provides insight into management's vested interest.

Related Party Transactions

• The acquisition of phantom stock by a director as part of a deferred compensation plan constitutes a related party transaction between the company and its director.

Stakeholder Impact

• Shareholders: The transaction demonstrates continued alignment of a director's interests with those of the shareholders, potentially fostering confidence in long-term value creation.

Next Steps

• The phantom stock will become payable in common stock upon the reporting person's termination of service as a director.

Key Dates

Recommendation

The acquisition of phantom stock by a director, even as part of a deferred compensation plan, signals continued commitment and alignment with the company's long-term performance, reinforcing a 'hold' stance for existing investors. While positive, it's a routine compensation event rather than a discretionary open-market purchase that would typically drive a 'buy' recommendation.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Director Compensation, Phantom Stock, Beneficial Ownership, Corporate Governance, Rule 10b5-1